Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-02

Clinical Trial Update: SARCOTHAL. Thalidomide in Skin Sarcoidosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating thalidomide for skin sarcoidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sarcoidosis | Phase 3 | Status: COMPLETED